Etiology of genetic muscle disorders induced by mutations in fast and slow skeletal MyBP-C paralogs
0
조회
0
다운로드
0
인용
0
참고문헌
초록
Skeletal muscle, a highly complex muscle type in the eukaryotic system, is characterized by different muscle subtypes and functions associated with specific myosin isoforms. As a result, skeletal muscle is the target of numerous diseases, including distal arthrogryposes (DAs). Clinically, DAs are a distinct disorder characterized by variation in the presence of contractures in two or more distal limb joints without neurological issues. DAs are inherited, and up to 40% of patients with this condition have mutations in genes that encode sarcomeric protein, including myosin heavy chains, troponins, and tropomyosin, as well as myosin binding protein-C (MYBPC). Our research group and others are actively studying the specific role of MYBPC in skeletal muscles. The MYBPC family of proteins plays a critical role in the contraction of striated muscles. More specifically, three paralogs of the MYBPC gene exist, and these are named after their predominant expression in slow-skeletal, fast-skeletal, and cardiac muscle as sMyBP-C, fMyBP-C, and cMyBP-C, respectively, and encoded by the MYBPC1, MYBPC2, and MYBPC3 genes, respectively. Although the physiology of various types of skeletal muscle diseases is well defined, the molecular mechanism underlying the pathological regulation of DAs remains to be elucidated. In this review article, we aim to highlight recent discoveries involving the role of skeletal muscle-specific sMyBP-C and fMyBP-C as well as their expression profile, localization in the sarcomere, and potential role(s) in regulating muscle contractility. Thus, this review provides an overall summary of MYBPC skeletal paralogs, their potential roles in skeletal muscle function, and future research directions.
Abstract
Skeletal muscle, a highly complex muscle type in the eukaryotic system, is characterized by different muscle subtypes and functions associated with specific myosin isoforms. As a result, skeletal muscle is the target of numerous diseases, including distal arthrogryposes (DAs). Clinically, DAs are a distinct disorder characterized by variation in the presence of contractures in two or more distal limb joints without neurological issues. DAs are inherited, and up to 40% of patients with this condition have mutations in genes that encode sarcomeric protein, including myosin heavy chains, troponins, and tropomyosin, as well as myosin binding protein-C (MYBPC). Our research group and others are actively studying the specific role of MYBPC in skeletal muscles. The MYBPC family of proteins plays a critical role in the contraction of striated muscles. More specifically, three paralogs of the MYBPC gene exist, and these are named after their predominant expression in slow-skeletal, fast-skeletal, and cardiac muscle as sMyBP-C, fMyBP-C, and cMyBP-C, respectively, and encoded by the MYBPC1, MYBPC2, and MYBPC3 genes, respectively. Although the physiology of various types of skeletal muscle diseases is well defined, the molecular mechanism underlying the pathological regulation of DAs remains to be elucidated. In this review article, we aim to highlight recent discoveries involving the role of skeletal muscle-specific sMyBP-C and fMyBP-C as well as their expression profile, localization in the sarcomere, and potential role(s) in regulating muscle contractility. Thus, this review provides an overall summary of MYBPC skeletal paralogs, their potential roles in skeletal muscle function, and future research directions.
참고문헌 (117)
- Gautel, M., "Isoform transitions of the myosin binding protein C family in developing human and mouse muscles : lack of isoform transcomplementation in cardiac muscle", Circ. Res, 82, pp.124~129 (1998)
- Starr, R., "Polypeptide chains of intermediate molecular weight in myosin preparations", FEBS Lett, 15, pp.40~44 (1971)
- Watkins, H., "Mutations in the cardiac myosin binding protein-C gene on chromosome 11 cause familial hypertrophic cardiomyopathy", Nat. Genet, 11, pp.434~437 (1995)
- Bonne, G., "Cardiac myosin binding protein-C gene splice acceptor site mutation is associated with familial hypertrophic cardiomyopathy", Nat. Genet, 11, pp.438~440 (1995)
- Carrier, L., "Cardiac myosin-binding protein C(MYBPC3)in cardiac pathophysiology", Gene, 573, pp.188~197 (2015)
- McNally, E. M., "The genetic landscape of cardiomyopathy and its role in heart failure", Cell Metab, 21, pp.174~182 (2015)
- van Velzen, H. G., "Clinical characteristics and long-term outcome of hypertrophic cardiomyopathy in individuals with a MYBPC3(Myosin-Binding Protein C)founder mutation", Circ. Cardiovasc. Genet, 10, pp.e001660~ (2017)
- McConnell, B. K., "Dilated cardiomyopathy in homozygous myosin-binding protein-C mutant mice", J. Clin. Invest, 104, pp.1235~1244 (1999)
- Yang, Q., "In vivo modeling of myosin binding protein C familial hypertrophic cardiomyopathy", Circ. Res, 85, pp.841~847 (1999)
- Harris, S. P., "Hypertrophic cardiomyopathy in cardiac myosin binding protein-C knockout mice", Circ. Res, 90, pp.594~601 (2002)
- Carrier, L., "Asymmetric septal hypertrophy in heterozygous cMyBP-C null mice", Cardiovasc. Res, 63, pp.293~304 (2004)
- Gautel, M., "Phosphorylation switches specific for the cardiac isoform of myosin binding protein-C: a modulator of cardiac contraction?", EMBO J, 14, pp.1952~1960 (1995)
- Previs, M. J., "Phosphorylation and calcium antagonistically tune myosinbinding protein C’s structure and function", Proc. Natl Acad. Sci. USA, 113, pp.3239~3244 (2016)
- Barefield, D., "Phosphorylation and function of cardiac myosin binding protein-C in health and disease", J. Mol. Cell. Cardiol, 48, pp.866~875 (2010)
- van Dijk, S. J., "Cardiac myosin-binding protein C mutations and hypertrophic cardiomyopathy : haploinsufficiency, deranged phosphorylation, and cardiomyocyte dysfunction", Circulation, 119, pp.1473~1483 (2009)
- Copeland, O., "Analysis of cardiac myosin binding protein-C phosphorylation in human heart muscle", J. Mol. Cell. Cardiol, 49, pp.1003~1011 (2010)
- Sadayappan, S., "Cardiac myosin binding protein C phosphorylation is cardioprotective", Proc. Natl Acad. Sci. USA, 103, pp.16918~16923 (2006)
- Sadayappan, S., "Cardiac myosin-binding protein-C phosphorylation and cardiac function", Circ. Res, 97, pp.1156~1163 (2005)
- Govindan, S., "Cardiac myosin binding protein-C is a potential diagnostic biomarker for myocardial infarction", J. Mol. Cell. Cardiol, 52, pp.154~164 (2012)
- Anand, A., "Cardiac myosin-binding protein C is a novel marker of myocardial injury and fibrosis in aortic stenosis", Heart, 104, pp.1101~1108 (2018)
- Marber, M. S., "Study Group on Biomarkers of the ESC Association for Acute CardioVascular Care Cardiac myosin-binding protein C as a biomarker of acute myocardial infarction", Eur. Heart J. Acute Cardiovasc. Care, 10, pp.963~965 (2021)
- Mun, J. Y., "Myosin-binding protein C displaces tropomyosin to activate cardiac thin filaments and governs their speed by an independent mechanism", Proc. Natl Acad. Sci. USA, 111, pp.2170~2175 (2014)
- Lynch, T. L. T., "Amino terminus of cardiac myosin binding protein-C regulates cardiac contractility", J. Mol. Cell. Cardiol, 156, pp.33~44 (2021)
- Gurnett, C. A., "Myosin binding protein C1 : a novel gene for autosomal dominant distal arthrogryposis type 1", Hum. Mol. Genet, 19, pp.1165~1173 (2010)
- McNamara, J. W., "Skeletal myosin binding protein-C : An increasingly important regulator of striated muscle physiology", Arch. Biochem. Biophys, 660, pp.121~128 (2018)
- Ackermann, M. A., "Myosin binding protein-C slow is a novel substrate for protein kinase A(PKA)and C(PKC)in skeletal muscle", J. Proteome Res, 10, pp.4547~4555 (2011)
- Song, T., "Fast skeletal myosin-binding protein-C regulates fast skeletal muscle contraction", Proc. Natl Acad. Sci. USA, 118, pp.e2003596118~ (2021)
- Geist, J., "Structure before function: myosin binding protein-C slow is a structural protein with regulatory properties", FASEB J, 32, pp.fj201800624R~ (2018)
- Hartzell, H. C., "Structure of C protein purified from cardiac muscle", J. Cell Biol, 100, pp.208~215 (1985)
- Heling, L., "MyBP-C : one protein to govern them all", J. Muscle Res. Cell Motil, 41, pp.91~101 (2020)
- Offer, G., "A new protein of the thick filaments of vertebrate skeletal myofibrils. Extractions, purification and characterization", J. Mol. Biol, 74, pp.653~676 (1973)
- Weber, F. E., "Complete sequence of human fast-type and slow-type muscle myosin-binding-protein C (MyBP-C). Differential expression, conserved domain structure and chromosome assignment", Eur. J. Biochem, 216, pp.661~669 (1993)
- Carrier, L., "Mapping of a novel gene for familial hypertrophic cardiomyopathy to chromosome 11", Nat. Genet, 4, pp.311~313 (1993)
- Kuster, D. W., "GSK3beta phosphorylates newly identified site in the prolinealanine-rich region of cardiac myosin-binding protein C and alters cross-bridge cycling kinetics in human : short communication", Circ. Res, 112, pp.633~639 (2013)
- Jia, W., "Identification of novel protein kinase A phosphorylation sites in the M-domain of human and murine cardiac myosin binding protein-C using mass spectrometry analysis", J. Proteome Res, 9, pp.1843~1853 (2010)
- Sadayappan, S., "A critical function for Ser-282 in cardiac Myosin binding protein-C phosphorylation and cardiac function", Circ. Res, 109, pp.141~150 (2011)
- Main, A., "Post-translational regulation of cardiac myosin binding protein-C : a graphical review", Cell. Signal, 76, pp.109788~ (2020)
- Figueiredo-Freitas, C., "S-Nitrosylation of sarcomeric proteins depresses myofilament Ca2+)sensitivity in intact cardiomyocytes", Antioxid. Redox Signal, 23, pp.1017~1034 (2015)
- Ackermann, M. A., "Myosin binding protein-C : a regulator of actomyosin interaction in striated muscle", J. Biomed. Biotechnol, 2011, pp.636403~ (2011)
- Dhoot, G. K., "Expression of slow skeletal myosin binding C-protein in normal adult mammalian heart", J. Muscle Res. Cell Motil, 26, pp.143~148 (2005)
- Lin, B., "Cardiac myosin binding protein-C plays no regulatory role in skeletal muscle structure and function", PLoS One, 8, pp.e69671~ (2013)
- Yasuda, M., "Complete primary structure of chicken cardiac C-protein(MyBP-C)and its expression in developing striated muscles", J. Mol. Cell. Cardiol, 27, pp.2275~2286 (1995)
- Fougerousse, F., "Cardiac myosin binding protein C gene is specifically expressed in heart during murine and human development", Circ. Res, 82, pp.130~133 (1998)
- Reinach, F. C., "Isoforms of C-protein in adult chicken skeletal muscle : detection with monoclonal antibodies", J. Cell Biol, 95, pp.78~84 (1982)
- Dhoot, G. K., "The isoforms of C protein and their distribution in mammalian skeletal muscle", J. Muscle Res. Cell Motil, 6, pp.487~505 (1985)
- Flashman, E., "Cardiac myosin binding protein C : its role in physiology and disease", Circ. Res, 94, pp.1279~1289 (2004)
- Reinach, F. C., "Characterization of the C-protein from posterior latissimus dorsi muscle of the adult chicken : heterogeneity within a single sarcomere", J. Cell Biol, 96, pp.297~300 (1983)
- Ackermann, M. A., "Myosin binding protein-C slow : a multifaceted family of proteins with a complex expression profile in fast and slow twitch skeletal muscles", Front. Physiol, 4, pp.391~ (2013)
- Ackermann, M. A., "Myosin binding protein-C slow : an intricate subfamily of proteins", J. Biomed. Biotechnol, 2010, pp.652065~ (2010)
- Kawashima, M., "The earliest form of C-protein expressed during striated muscle development is immunologically the same as cardiac-type C-protein", J. Biochem, 99, pp.1037~1047 (1986)
- Kurasawa, M., "Differential expression of C-protein isoforms in developing and degenerating mouse striated muscles", Muscle Nerve, 22, pp.196~207 (1999)
- Gordon, A. M., "Regulation of contraction in striated muscle", Physiol. Rev, 80, pp.853~924 (2000)
- Gupta, M. K., "Post-translational control of cardiac hemodynamics through myosin binding protein C", Pflug. Arch, 466, pp.231~236 (2014)
- Bardswell, S. C., "Distinct sarcomeric substrates are responsible for protein kinase D-mediated regulation of cardiac myofilament Ca2+ sensitivity and cross-bridge cycling", J. Biol. Chem, 285, pp.5674~5682 (2010)
- Cuello, F., "Novel role for p90 ribosomal S6 kinase in the regulation of cardiac myofilament phosphorylation", J. Biol. Chem, 286, pp.5300~5310 (2011)
- Mohamed, A. S., "Cardiac myosin-binding protein C(MyBP-C) : identification of protein kinase A and protein kinase C phosphorylation sites", Arch. Biochem. Biophys, 358, pp.313~319 (1998)
- Bardswell, S. C., "cMyBP-C as a promiscuous substrate : phosphorylation by non-PKA kinases and its potential significance", J. Muscle Res. Cell Motil, 33, pp.53~60 (2012)
- Robinett, J. C., "Regulation of myofilament force and loaded shortening by skeletal myosin binding protein C", J. Gen. Physiol, 151, pp.645~659 (2019)
- Hartzell, H. C., "Phosphorylation of C-protein in intact amphibian cardiac muscle. Correlation between 32P incorporation and twitch relaxation", J. Gen. Physiol, 83, pp.563~588 (1984)
- Kunst, G., "Myosin binding protein C, a phosphorylation-dependent force regulator in muscle that controls the attachment of myosin heads by its interaction with myosin S2", Circ. Res, 86, pp.51~58 (2000)
- Harris, S. P., "Binding of myosin binding protein-C to myosin subfragment S2 affects contractility independent of a tether mechanism", Circ. Res, 95, pp.930~936 (2004)
- McClellan, G., "Changes in cardiac contractility related to calcium-mediated changes in phosphorylation of myosin-binding protein C", Biophys. J, 81, pp.1083~1092 (2001)
- Weisberg, A., "Alteration of myosin cross bridges by phosphorylation of myosin-binding protein C in cardiac muscle", Proc. Natl Acad. Sci. USA, 93, pp.8999~9003 (1996)
- Weisberg, A., "Relation between crossbridge structure and actomyosin ATPase activity in rat heart", Circ. Res, 83, pp.60~72 (1998)
- Caremani, M., "Inotropic interventions do not change the resting state of myosin motors during cardiac diastole", J. Gen. Physiol, 151, pp.53~65 (2019)
- Craig, R., "Structural basis of the super-and hyper-relaxed states of myosin II", J. Gen. Physiol, 154, pp.e202113012~ (2022)
- Irving, T. C., "Getting into the thick(and thin)of it", J. Gen. Physiol, 151, pp.610~613 (2019)
- Kensler, R. W., "Phosphorylation of cardiac myosin binding protein C releases myosin heads from the surface of cardiac thick filaments", Proc. Natl Acad. Sci. USA, 114, pp.E1355~E1364 (2017)
- Mun, J. Y., "Electron microscopy and 3D reconstruction of F-actin decorated with cardiac myosin-binding protein C(cMyBP-C)", J. Mol. Biol, 410, pp.214~225 (2011)
- Ratti, J., "Structure and interactions of myosinbinding protein C domain C0 : cardiac-specific regulation of myosin at its neck? J", Biol. Chem, 286, pp.12650~12658 (2011)
- Razumova, M. V., "Effects of the N-terminal domains of myosin binding protein-C in an in vitro motility assay : Evidence for long-lived cross-bridges", J. Biol. Chem, 281, pp.35846~35854 (2006)
- Gruen, M., "Mutations in beta-myosin S2 that cause familial hypertrophic cardiomyopathy(FHC)abolish the interaction with the regulatory domain of myosin-binding protein-C", J. Mol. Biol, 286, pp.933~949 (1999)
- Gruen, M., "cAPK-phosphorylation controls the interaction of the regulatory domain of cardiac myosin binding protein C with myosin-S2 in an on-off fashion", FEBS Lett, 453, pp.254~259 (1999)
- Kulikovskaya, I., "Effect of MyBP-C binding to actin on contractility in heart muscle", J. Gen. Physiol, 122, pp.761~774 (2003)
- Levine, R., "Multiple structures of thick filaments in resting cardiac muscle and their influence on cross-bridge interactions", Biophys. J, 81, pp.1070~1082 (2001)
- Rahmanseresht, S., "The N terminus of myosin-binding protein C extends toward actin filaments in intact cardiac muscle", J. Gen. Physiol, 153, pp.e202012726~ (2021)
- Previs, M. J, "Molecular modulation of actomyosin function by cardiac myosin-binding protein C", Pflug. Arch, 466, pp.439~444 (2014)
- Previs, M. J., "Molecular mechanics of cardiac myosin-binding protein C in native thick filaments", Science, 337, pp.1215~1218 (2012)
- Moss, R. L., "Cardiac MyBP-C regulates the rate and force of contraction in mammalian myocardium", Circ. Res, 116, pp.183~192 (2015)
- Oakley, C. E., "Myosin binding protein-C:enigmatic regulator of cardiac contraction", Int J. Biochem. Cell Biol, 39, pp.2161~2166 (2007)
- Pfuhl, M., "Structure, interactions and function of the N-terminus of cardiac myosin binding protein C(MyBP-C) : who does what, with what, and to whom? J", Muscle Res. Cell Motil, 33, pp.83~94 (2012)
- Yang, Q., "PKA-dependent phosphorylation of cardiac myosin binding protein C in transgenic mice", Cardiovasc. Res, 51, pp.80~88 (2001)
- Hanft, L. M., "Molecule specific effects of PKA-mediated phosphorylation on rat isolated heart and cardiac myofibrillar function", Arch. Biochem. Biophys, 601, pp.22~31 (2016)
- Stelzer, J. E., "Protein kinase A-mediated acceleration of the stretch activation response in murine skinned myocardium is eliminated by ablation of cMyBP-C", Circ. Res, 99, pp.884~890 (2006)
- Hanft, L. M., "Sarcomere length dependence of power output is increased after PKA treatment in rat cardiac myocytes", Am. J. Physiol. Heart Circ. Physiol, 296, pp.H1524~H1531 (2009)
- Lin, B. L., "Skeletal myosin binding protein-C isoforms regulate thin filament activity in a Ca(2+)-dependent manner", Sci. Rep, 8, pp.2604~ (2018)
- Kampourakis, T., "Myosin binding protein-C activates thin filaments and inhibits thick filaments in heart muscle cells", Proc. Natl Acad. Sci. USA, 111, pp.18763~18768 (2014)
- Caremani, M., "Low temperature traps myosin motors of mammalian muscle in a refractory state that prevents activation", J. Gen. Physiol, 151, pp.1272~1286 (2019)
- Napierski, N. C., "A novel"cut and paste"method for in situ replacement of cMyBP-C reveals a new role for cMyBP-C in the regulation of contractile oscillations", Circ. Res, 126, pp.737~749 (2020)
- McNamara, J. W., "Cardiac myosin binding protein-C phosphorylation regulates the super-relaxed state of myosin", Proc. Natl Acad. Sci. USA, 116, pp.11731~11736 (2019)
- Woodhead, J. L., "Atomic model of a myosin filament in the relaxed state", Nature, 436, pp.1195~1199 (2005)
- Zoghbi, M. E., "Three-dimensional structure of vertebrate cardiac muscle myosin filaments", Proc. Natl Acad. Sci. USA, 105, pp.2386~2390 (2008)
- Nelson, S. R., "Imaging ATP consumption in resting skeletal muscle: one molecule at a time", Biophys. J, 119, pp.1050~1055 (2020)
- Brunello, E., "Myosin filament-based regulation of the dynamics of contraction in heart muscle", Proc. Natl Acad. Sci. USA, 117, pp.8177~8186 (2020)
- Nag, S., "The myosin mesa and the basis of hypercontractility caused by hypertrophic cardiomyopathy mutations", Nat. Struct. Mol. Biol, 24, pp.525~533 (2017)
- Sarkar, S. S., "The hypertrophic cardiomyopathy mutations R403Q and R663H increase the number of myosin heads available to interact with actin", Sci. Adv, 6, pp.eaax0069~ (2020)
- Trivedi, D. V., "Hypertrophic cardiomyopathy and the myosin mesa : viewing an old disease in a new light", Biophys. Rev, 10, pp.27~48 (2018)
- McNamara, J. W., "Ablation of cardiac myosin binding protein-C disrupts the super-relaxed state of myosin in murine cardiomyocytes", J. Mol. Cell. Cardiol, 94, pp.65~71 (2016)
- Semsarian, C., "New perspectives on the prevalence of hypertrophic cardiomyopathy", J. Am. Coll. Cardiol, 65, pp.1249~1254 (2015)
- Ross, S. B., "Burden of recurrent and ancestral mutations in families with hypertrophic cardiomyopathy", Circ. Cardiovasc. Genet, 10, pp.e001671~ (2017)
- Kuster, D. W., "A hypertrophic cardiomyopathy-associated MYBPC3 mutation common in populations of South Asian descent causes contractile dysfunction", J. Biol. Chem, 290, pp.5855~5867 (2015)
- McConnell, B. K., "Dilated cardiomyopathy in homozygous myosin-binding protein-C mutant mice", J. Clin. Invest, 104, pp.1771~ (1999)
- Helms, A. S., "Effects of MYBPC3 loss-of-function mutations preceding hypertrophic cardiomyopathy", JCI Insight, 5, pp.e133782~ (2020)
- Toepfer, C. N., "Hypertrophic cardiomyopathy mutations in MYBPC3 dysregulate myosin", Sci. Transl. Med, 11, pp.eaat1199~ (2019)
- Lynch, T. L., "Surviving the infarct : a profile of cardiac myosin binding protein-C pathogenicity, diagnostic utility, and proteomics in the ischemic myocardium", Proteom. Clin. Appl, 8, pp.569~577 (2014)
- Govindan, S., "Pathogenic properties of the N-terminal region of cardiac myosin binding protein-C in vitro", J. Muscle Res. Cell Motil, 33, pp.17~30 (2012)
- Geist Hauserman, J., "Sarcomeric deficits underlie MYBPC1-associated myopathy with myogenic tremor", JCI Insight, 6, pp.e147612~ (2021)
- Ackermann, M. A., "The phosphorylation profile of myosin binding protein-C slow is dynamically regulated in slow-twitch muscles in health and disease", Sci. Rep, 5, pp.12637~ (2015)
- Ackermann, M. A., "Myosin binding protein-C slow phosphorylation is altered in duchenne dystrophy and arthrogryposis myopathy in fast-twitch skeletal muscles", Sci. Rep, 5, pp.13235~ (2015)
- Bayram, Y., "Molecular etiology of arthrogryposis in multiple families of mostly Turkish origin", J. Clin. Invest, 126, pp.762~778 (2016)
- Li, A., "Skeletal MyBP-C isoforms tune the molecular contractility of divergent skeletal muscle systems", Proc. Natl Acad. Sci. USA, 116, pp.21882~21892 (2019)
- Chen, Z., "MYBPC2 and MYL1 as Significant Gene Markers for Rhabdomyosarcoma", Technol. Cancer Res. Treat, 20, pp.1~15 (2021)
- Ducret, V., "Transcriptomic analysis of the trade-off between endurance and burst-performance in the frog Xenopus allofraseri", BMC Genomics, 22, pp.204~ (2021)
- Li, X., "Two novel mutations in myosin binding protein C slow causing distal arthrogryposis type 2 in two large Han Chinese families may suggest important functional role of immunoglobulin domain C2", PLoS One, 10, pp.e0117158~ (2015)
- Stavusis, J., "Novel mutations in MYBPC1 are associated with myogenic tremor and mild myopathy", Ann. Neurol, 86, pp.129~142 (2019)
- Ha, K., "MYBPC1 mutations impair skeletal muscle function in zebrafish models of arthrogryposis", Hum. Mol. Genet, 22, pp.4967~4977 (2013)
- Li, M., "Knockdown of fast skeletal myosin-binding protein C in zebrafish results in a severe skeletal myopathy", J. Gen. Physiol, 147, pp.309~322 (2016)
